SAR439774, SAR439774
EFC17905
Phase 3 small_molecule active
Quick answer
SAR439774, SAR439774 for Hemophilia is a Phase 3 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Hemophilia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active